Castle Biosciences, Inc. (CSTL)
NASDAQ · Healthcare
Castle Biosciences, Inc. Shareholder Equity 2018–2025
Castle Biosciences, Inc. annual shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Castle Biosciences, Inc. shareholder equity as of December 31, 2025: 470.9M, a 3.30% increase year-over-year.
- Castle Biosciences, Inc. shareholder equity for 2025 were 470.9M, a 3.30% increase from 2024.
- Castle Biosciences, Inc. shareholder equity for 2024 were 455.8M, a 16.50% increase from 2023.
- Castle Biosciences, Inc. shareholder equity for 2023 were 391.3M, a 1.97% decrease from 2022.
- Castle Biosciences, Inc. shareholder equity for 2022 were 399.1M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Castle Biosciences, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $471 |
| 2024 | $456 |
| 2023 | $391 |
| 2022 | $399 |
| 2021 | $412 |
| 2020 | $416 |
| 2019 | $85 |
| 2018 | $-57 |
Castle Biosciences, Inc. Shareholder Equity — FAQ
Castle Biosciences, Inc. (CSTL) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CSTL's shareholder equity history?
The chart and table above show Castle Biosciences, Inc.'s shareholder equity by year and by quarter, including the growth rate.